GENE ONLINE|News &
Trials & Approvals
FDA Approves PADCEV and Keytruda Perioperative Therapy: A Game-Changer for Cisplatin-Ineligible Bladder Cancer Patients
2025-11-27
AstraZeneca’s Imfinzi Wins U.S. Approval for Perioperative Gastric Cancer Treatment with FLOT
2025-11-26
FDA Approves Roche’s Gazyva for Lupus Nephritis, Bringing New Hope to 1.7 Million Patients Worldwide
2025-10-21
EGFR Lung Cancer 2025: AstraZeneca’s Tagrisso vs J&J’s Rybrevant in Global Trials Highlight Efficacy and Tolerability Trade-Offs
2025-09-30
At-Home Alzheimer’s Therapy: FDA Clears Leqembi IQLIK Autoinjector for Maintenance Dosing
2025-09-03
2025 Alzheimer’s Drug Development: From Anti-Amyloid to Next-Gen Targets and a $15.5B Market Opportunity
2025-08-11
Leqembi Makes History as First EU-Approved Drug to Target Root Cause of Alzheimer’s Disease
2025-04-15
LATEST
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
Retired DEA Judge John Mulrooney and Attorney Andrew Hull to Present on Controlled Substances at January 2026 ACI Summit
2026-01-12
Thermal Cycloaddition Achieves Synthesis of Gem-Difluoro Bicycloalkanes for Medicinal Chemistry
2026-01-12
Study Explores Gene Expression Changes in Freeze-Tolerant Vertebrates During Subzero Conditions
2026-01-12
Study Explores Water-Use Efficiency and Heat Tolerance in Lasiurus sindicus for Survival in Arid Ecosystems
2026-01-12
